JP Morgan Chase’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,459
| Closed | -$1.17M | – | 7856 |
|
|
2024
Q1 | $1.17M | Sell |
29,459
-3,615
| -11% | -$107K | ﹤0.01% | 4230 |
|
|
2023
Q4 | $630K | Buy |
33,074
+1,765
| +6% | +$24.5K | ﹤0.01% | 4645 |
|
|
2023
Q3 | $358K | Buy |
31,309
+4,960
| +19% | +$61K | ﹤0.01% | 4681 |
|
|
2023
Q2 | $271K | Sell |
26,349
-21,800
| -45% | -$197K | ﹤0.01% | 4889 |
|
|
2023
Q1 | $372K | Buy |
48,149
+33,919
| +238% | +$270K | ﹤0.01% | 4678 |
|
|
2022
Q4 | $105K | Buy |
14,230
+3,657
| +35% | +$23.4K | ﹤0.01% | 5340 |
|
|
2022
Q3 | $77K | Buy |
10,573
+904
| +9% | +$7.45K | ﹤0.01% | 5404 |
|
|
2022
Q2 | $82K | Buy |
9,669
+722
| +8% | +$6.22K | ﹤0.01% | 5502 |
|
|
2022
Q1 | $80K | Buy |
8,947
+1,697
| +23% | +$14.7K | ﹤0.01% | 5606 |
|
|
2021
Q4 | $101K | Buy |
7,250
+2,790
| +63% | +$34.6K | ﹤0.01% | 5674 |
|
|
2021
Q3 | $48K | Hold |
4,460
| – | – | ﹤0.01% | 5855 |
|
|
2021
Q2 | $40K | Buy |
+4,460
| New | +$48.5K | ﹤0.01% | 5796 |
|
|
2021
Q1 | – | Sell |
-5,830
| Closed | -$73K | – | 6437 |
|
|
2020
Q4 | $73K | Buy |
5,830
+5,827
| +194,233% | +$57.2K | ﹤0.01% | 5065 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5862 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | +$13 | ﹤0.01% | 5778 |
|
|
2017
Q4 | – | Sell |
-2,600
| Closed | -$30K | – | 5619 |
|
|
2017
Q3 | $30K | Buy |
2,600
+1,000
| +63% | +$9.35K | ﹤0.01% | 4569 |
|
|
2017
Q2 | $15K | Buy |
+1,600
| New | +$15.3K | ﹤0.01% | 4594 |
|
|
2016
Q4 | – | Sell |
-484
| Closed | -$16K | – | 5175 |
|
|
2016
Q3 | $16K | Buy |
484
+410
| +554% | +$9.98K | ﹤0.01% | 4234 |
|
|
2016
Q2 | $1K | Sell |
74
-72,275
| -100% | -$1.28M | ﹤0.01% | 4705 |
|
|
2016
Q1 | $1.21M | Sell |
72,349
-1,201
| -2% | -$24K | ﹤0.01% | 2981 |
|
|
2015
Q4 | $2.28M | Sell |
73,550
-9,693
| -12% | -$331K | ﹤0.01% | 2694 |
|
|
2015
Q3 | $4.32M | Buy |
83,243
+9,595
| +13% | +$630K | ﹤0.01% | 2315 |
|
|
2015
Q2 | $4.46M | Buy |
+73,648
| New | +$4.39M | ﹤0.01% | 2458 |
|
JP Morgan Chase's ALPN Position: Q2 2024 in Review
JP Morgan Chase sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 29,459 shares — an estimated $1.17M sold.
JP Morgan Chase first reported a position in ALPN in Q2 2015 and held it in 23 quarters. The position peaked at $4.46M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- JP Morgan Chase reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- JP Morgan Chase sold 29,459 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.17M.
- JP Morgan Chase first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 23 quarters.
- JP Morgan Chase's Alpine Immune Sciences Inc position peaked at $4.46M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.